Migraine Therapeutics Market - Global Outlook and Forecast 2022-2028
Migraines are a family of recurrent attacks.The symptom is paroxysmal unilateral throbbing headache, accompanied by nausea, vomiting and confusion. Migraine therapeutics includes triptans, acetylcholine inhibitors/neurotoxins, ergot alkaloids, nsaids, ditan, CGRP small molecule antagonists, CGRP monoclonal antibodies, etc.
This report contains market size and forecasts of Migraine Therapeutics in Global, including the following market information:
Global Migraine Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Migraine Therapeutics market was valued at 5088.5 million in 2021 and is projected to reach US$ 6783 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Specific Anti-migraine Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Migraine Therapeutics include Allergan, Merck, Pfizer, Teva, Amgen, Johnson & Johnson, Endo International, GlaxoSmithKline and Impax, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Migraine Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Migraine Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Migraine Therapeutics Market Segment Percentages, by Type, 2021 (%)
Global Migraine Therapeutics Market Segment Percentages, by Application, 2021 (%)
Global Migraine Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Migraine Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Migraine Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Migraine Therapeutics in Global, including the following market information:
Global Migraine Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Migraine Therapeutics market was valued at 5088.5 million in 2021 and is projected to reach US$ 6783 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Specific Anti-migraine Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Migraine Therapeutics include Allergan, Merck, Pfizer, Teva, Amgen, Johnson & Johnson, Endo International, GlaxoSmithKline and Impax, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Migraine Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Migraine Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Migraine Therapeutics Market Segment Percentages, by Type, 2021 (%)
- Specific Anti-migraine Drugs
- Acute Therapies
- Preventative Therapies
- Other
Global Migraine Therapeutics Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Household Use
- Others
Global Migraine Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Migraine Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Migraine Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Allergan
- Merck
- Pfizer
- Teva
- Amgen
- Johnson & Johnson
- Endo International
- GlaxoSmithKline
- Impax
- Abbott
- Bayer
- Eli Lilly
- Novartis International
- Ethypharm
- Kowa Pharmaceuticals America
- Winston Pharmaceuticals
- AstraZeneca
- Amirall
- OptiNose
- Revance Therapeutics
- RedHill Biopharma
- Bausch Health
- NeurAxon
- Biohaven Pharma
- Eisai
- Valeant Pharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Migraine Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Migraine Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MIGRAINE THERAPEUTICS OVERALL MARKET SIZE
2.1 Global Migraine Therapeutics Market Size: 2021 VS 2028
2.2 Global Migraine Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Migraine Therapeutics Players in Global Market
3.2 Top Global Migraine Therapeutics Companies Ranked by Revenue
3.3 Global Migraine Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Migraine Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Migraine Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Migraine Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Migraine Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Migraine Therapeutics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Migraine Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Specific Anti-migraine Drugs
4.1.3 Acute Therapies
4.1.4 Preventative Therapies
4.1.5 Other
4.2 By Type - Global Migraine Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Migraine Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Migraine Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Migraine Therapeutics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Migraine Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Household Use
5.1.5 Others
5.2 By Application - Global Migraine Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Migraine Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Migraine Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Migraine Therapeutics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Migraine Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Migraine Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Migraine Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Migraine Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Migraine Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Migraine Therapeutics Revenue, 2017-2028
6.3.2 US Migraine Therapeutics Market Size, 2017-2028
6.3.3 Canada Migraine Therapeutics Market Size, 2017-2028
6.3.4 Mexico Migraine Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Migraine Therapeutics Revenue, 2017-2028
6.4.2 Germany Migraine Therapeutics Market Size, 2017-2028
6.4.3 France Migraine Therapeutics Market Size, 2017-2028
6.4.4 U.K. Migraine Therapeutics Market Size, 2017-2028
6.4.5 Italy Migraine Therapeutics Market Size, 2017-2028
6.4.6 Russia Migraine Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Migraine Therapeutics Market Size, 2017-2028
6.4.8 Benelux Migraine Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Migraine Therapeutics Revenue, 2017-2028
6.5.2 China Migraine Therapeutics Market Size, 2017-2028
6.5.3 Japan Migraine Therapeutics Market Size, 2017-2028
6.5.4 South Korea Migraine Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Migraine Therapeutics Market Size, 2017-2028
6.5.6 India Migraine Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Migraine Therapeutics Revenue, 2017-2028
6.6.2 Brazil Migraine Therapeutics Market Size, 2017-2028
6.6.3 Argentina Migraine Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Migraine Therapeutics Revenue, 2017-2028
6.7.2 Turkey Migraine Therapeutics Market Size, 2017-2028
6.7.3 Israel Migraine Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Migraine Therapeutics Market Size, 2017-2028
6.7.5 UAE Migraine Therapeutics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Migraine Therapeutics Major Product Offerings
7.1.4 Allergan Migraine Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Allergan Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Migraine Therapeutics Major Product Offerings
7.2.4 Merck Migraine Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Migraine Therapeutics Major Product Offerings
7.3.4 Pfizer Migraine Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Migraine Therapeutics Major Product Offerings
7.4.4 Teva Migraine Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Teva Key News
7.5 Amgen
7.5.1 Amgen Corporate Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Migraine Therapeutics Major Product Offerings
7.5.4 Amgen Migraine Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Amgen Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Migraine Therapeutics Major Product Offerings
7.6.4 Johnson & Johnson Migraine Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Endo International
7.7.1 Endo International Corporate Summary
7.7.2 Endo International Business Overview
7.7.3 Endo International Migraine Therapeutics Major Product Offerings
7.7.4 Endo International Migraine Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Endo International Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Migraine Therapeutics Major Product Offerings
7.8.4 GlaxoSmithKline Migraine Therapeutics Revenue in Global Market (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 Impax
7.9.1 Impax Corporate Summary
7.9.2 Impax Business Overview
7.9.3 Impax Migraine Therapeutics Major Product Offerings
7.9.4 Impax Migraine Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Impax Key News
7.10 Abbott
7.10.1 Abbott Corporate Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Migraine Therapeutics Major Product Offerings
7.10.4 Abbott Migraine Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Abbott Key News
7.11 Bayer
7.11.1 Bayer Corporate Summary
7.11.2 Bayer Business Overview
7.11.3 Bayer Migraine Therapeutics Major Product Offerings
7.11.4 Bayer Migraine Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Bayer Key News
7.12 Eli Lilly
7.12.1 Eli Lilly Corporate Summary
7.12.2 Eli Lilly Business Overview
7.12.3 Eli Lilly Migraine Therapeutics Major Product Offerings
7.12.4 Eli Lilly Migraine Therapeutics Revenue in Global Market (2017-2022)
7.12.5 Eli Lilly Key News
7.13 Novartis International
7.13.1 Novartis International Corporate Summary
7.13.2 Novartis International Business Overview
7.13.3 Novartis International Migraine Therapeutics Major Product Offerings
7.13.4 Novartis International Migraine Therapeutics Revenue in Global Market (2017-2022)
7.13.5 Novartis International Key News
7.14 Ethypharm
7.14.1 Ethypharm Corporate Summary
7.14.2 Ethypharm Business Overview
7.14.3 Ethypharm Migraine Therapeutics Major Product Offerings
7.14.4 Ethypharm Migraine Therapeutics Revenue in Global Market (2017-2022)
7.14.5 Ethypharm Key News
7.15 Kowa Pharmaceuticals America
7.15.1 Kowa Pharmaceuticals America Corporate Summary
7.15.2 Kowa Pharmaceuticals America Business Overview
7.15.3 Kowa Pharmaceuticals America Migraine Therapeutics Major Product Offerings
7.15.4 Kowa Pharmaceuticals America Migraine Therapeutics Revenue in Global Market (2017-2022)
7.15.5 Kowa Pharmaceuticals America Key News
7.16 Winston Pharmaceuticals
7.16.1 Winston Pharmaceuticals Corporate Summary
7.16.2 Winston Pharmaceuticals Business Overview
7.16.3 Winston Pharmaceuticals Migraine Therapeutics Major Product Offerings
7.16.4 Winston Pharmaceuticals Migraine Therapeutics Revenue in Global Market (2017-2022)
7.16.5 Winston Pharmaceuticals Key News
7.17 AstraZeneca
7.17.1 AstraZeneca Corporate Summary
7.17.2 AstraZeneca Business Overview
7.17.3 AstraZeneca Migraine Therapeutics Major Product Offerings
7.17.4 AstraZeneca Migraine Therapeutics Revenue in Global Market (2017-2022)
7.17.5 AstraZeneca Key News
7.18 Amirall
7.18.1 Amirall Corporate Summary
7.18.2 Amirall Business Overview
7.18.3 Amirall Migraine Therapeutics Major Product Offerings
7.18.4 Amirall Migraine Therapeutics Revenue in Global Market (2017-2022)
7.18.5 Amirall Key News
7.19 OptiNose
7.19.1 OptiNose Corporate Summary
7.19.2 OptiNose Business Overview
7.19.3 OptiNose Migraine Therapeutics Major Product Offerings
7.19.4 OptiNose Migraine Therapeutics Revenue in Global Market (2017-2022)
7.19.5 OptiNose Key News
7.20 Revance Therapeutics
7.20.1 Revance Therapeutics Corporate Summary
7.20.2 Revance Therapeutics Business Overview
7.20.3 Revance Therapeutics Migraine Therapeutics Major Product Offerings
7.20.4 Revance Therapeutics Migraine Therapeutics Revenue in Global Market (2017-2022)
7.20.5 Revance Therapeutics Key News
7.21 RedHill Biopharma
7.21.1 RedHill Biopharma Corporate Summary
7.21.2 RedHill Biopharma Business Overview
7.21.3 RedHill Biopharma Migraine Therapeutics Major Product Offerings
7.21.4 RedHill Biopharma Migraine Therapeutics Revenue in Global Market (2017-2022)
7.21.5 RedHill Biopharma Key News
7.22 Bausch Health
7.22.1 Bausch Health Corporate Summary
7.22.2 Bausch Health Business Overview
7.22.3 Bausch Health Migraine Therapeutics Major Product Offerings
7.22.4 Bausch Health Migraine Therapeutics Revenue in Global Market (2017-2022)
7.22.5 Bausch Health Key News
7.23 NeurAxon
7.23.1 NeurAxon Corporate Summary
7.23.2 NeurAxon Business Overview
7.23.3 NeurAxon Migraine Therapeutics Major Product Offerings
7.23.4 NeurAxon Migraine Therapeutics Revenue in Global Market (2017-2022)
7.23.5 NeurAxon Key News
7.24 Biohaven Pharma
7.24.1 Biohaven Pharma Corporate Summary
7.24.2 Biohaven Pharma Business Overview
7.24.3 Biohaven Pharma Migraine Therapeutics Major Product Offerings
7.24.4 Biohaven Pharma Migraine Therapeutics Revenue in Global Market (2017-2022)
7.24.5 Biohaven Pharma Key News
7.25 Eisai
7.25.1 Eisai Corporate Summary
7.25.2 Eisai Business Overview
7.25.3 Eisai Migraine Therapeutics Major Product Offerings
7.25.4 Eisai Migraine Therapeutics Revenue in Global Market (2017-2022)
7.25.5 Eisai Key News
7.26 Valeant Pharma
7.26.1 Valeant Pharma Corporate Summary
7.26.2 Valeant Pharma Business Overview
7.26.3 Valeant Pharma Migraine Therapeutics Major Product Offerings
7.26.4 Valeant Pharma Migraine Therapeutics Revenue in Global Market (2017-2022)
7.26.5 Valeant Pharma Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Migraine Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Migraine Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MIGRAINE THERAPEUTICS OVERALL MARKET SIZE
2.1 Global Migraine Therapeutics Market Size: 2021 VS 2028
2.2 Global Migraine Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Migraine Therapeutics Players in Global Market
3.2 Top Global Migraine Therapeutics Companies Ranked by Revenue
3.3 Global Migraine Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Migraine Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Migraine Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Migraine Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Migraine Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Migraine Therapeutics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Migraine Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Specific Anti-migraine Drugs
4.1.3 Acute Therapies
4.1.4 Preventative Therapies
4.1.5 Other
4.2 By Type - Global Migraine Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Migraine Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Migraine Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Migraine Therapeutics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Migraine Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Household Use
5.1.5 Others
5.2 By Application - Global Migraine Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Migraine Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Migraine Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Migraine Therapeutics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Migraine Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Migraine Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Migraine Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Migraine Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Migraine Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Migraine Therapeutics Revenue, 2017-2028
6.3.2 US Migraine Therapeutics Market Size, 2017-2028
6.3.3 Canada Migraine Therapeutics Market Size, 2017-2028
6.3.4 Mexico Migraine Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Migraine Therapeutics Revenue, 2017-2028
6.4.2 Germany Migraine Therapeutics Market Size, 2017-2028
6.4.3 France Migraine Therapeutics Market Size, 2017-2028
6.4.4 U.K. Migraine Therapeutics Market Size, 2017-2028
6.4.5 Italy Migraine Therapeutics Market Size, 2017-2028
6.4.6 Russia Migraine Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Migraine Therapeutics Market Size, 2017-2028
6.4.8 Benelux Migraine Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Migraine Therapeutics Revenue, 2017-2028
6.5.2 China Migraine Therapeutics Market Size, 2017-2028
6.5.3 Japan Migraine Therapeutics Market Size, 2017-2028
6.5.4 South Korea Migraine Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Migraine Therapeutics Market Size, 2017-2028
6.5.6 India Migraine Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Migraine Therapeutics Revenue, 2017-2028
6.6.2 Brazil Migraine Therapeutics Market Size, 2017-2028
6.6.3 Argentina Migraine Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Migraine Therapeutics Revenue, 2017-2028
6.7.2 Turkey Migraine Therapeutics Market Size, 2017-2028
6.7.3 Israel Migraine Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Migraine Therapeutics Market Size, 2017-2028
6.7.5 UAE Migraine Therapeutics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Migraine Therapeutics Major Product Offerings
7.1.4 Allergan Migraine Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Allergan Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Migraine Therapeutics Major Product Offerings
7.2.4 Merck Migraine Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Migraine Therapeutics Major Product Offerings
7.3.4 Pfizer Migraine Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Migraine Therapeutics Major Product Offerings
7.4.4 Teva Migraine Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Teva Key News
7.5 Amgen
7.5.1 Amgen Corporate Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Migraine Therapeutics Major Product Offerings
7.5.4 Amgen Migraine Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Amgen Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Migraine Therapeutics Major Product Offerings
7.6.4 Johnson & Johnson Migraine Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Endo International
7.7.1 Endo International Corporate Summary
7.7.2 Endo International Business Overview
7.7.3 Endo International Migraine Therapeutics Major Product Offerings
7.7.4 Endo International Migraine Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Endo International Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Migraine Therapeutics Major Product Offerings
7.8.4 GlaxoSmithKline Migraine Therapeutics Revenue in Global Market (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 Impax
7.9.1 Impax Corporate Summary
7.9.2 Impax Business Overview
7.9.3 Impax Migraine Therapeutics Major Product Offerings
7.9.4 Impax Migraine Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Impax Key News
7.10 Abbott
7.10.1 Abbott Corporate Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Migraine Therapeutics Major Product Offerings
7.10.4 Abbott Migraine Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Abbott Key News
7.11 Bayer
7.11.1 Bayer Corporate Summary
7.11.2 Bayer Business Overview
7.11.3 Bayer Migraine Therapeutics Major Product Offerings
7.11.4 Bayer Migraine Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Bayer Key News
7.12 Eli Lilly
7.12.1 Eli Lilly Corporate Summary
7.12.2 Eli Lilly Business Overview
7.12.3 Eli Lilly Migraine Therapeutics Major Product Offerings
7.12.4 Eli Lilly Migraine Therapeutics Revenue in Global Market (2017-2022)
7.12.5 Eli Lilly Key News
7.13 Novartis International
7.13.1 Novartis International Corporate Summary
7.13.2 Novartis International Business Overview
7.13.3 Novartis International Migraine Therapeutics Major Product Offerings
7.13.4 Novartis International Migraine Therapeutics Revenue in Global Market (2017-2022)
7.13.5 Novartis International Key News
7.14 Ethypharm
7.14.1 Ethypharm Corporate Summary
7.14.2 Ethypharm Business Overview
7.14.3 Ethypharm Migraine Therapeutics Major Product Offerings
7.14.4 Ethypharm Migraine Therapeutics Revenue in Global Market (2017-2022)
7.14.5 Ethypharm Key News
7.15 Kowa Pharmaceuticals America
7.15.1 Kowa Pharmaceuticals America Corporate Summary
7.15.2 Kowa Pharmaceuticals America Business Overview
7.15.3 Kowa Pharmaceuticals America Migraine Therapeutics Major Product Offerings
7.15.4 Kowa Pharmaceuticals America Migraine Therapeutics Revenue in Global Market (2017-2022)
7.15.5 Kowa Pharmaceuticals America Key News
7.16 Winston Pharmaceuticals
7.16.1 Winston Pharmaceuticals Corporate Summary
7.16.2 Winston Pharmaceuticals Business Overview
7.16.3 Winston Pharmaceuticals Migraine Therapeutics Major Product Offerings
7.16.4 Winston Pharmaceuticals Migraine Therapeutics Revenue in Global Market (2017-2022)
7.16.5 Winston Pharmaceuticals Key News
7.17 AstraZeneca
7.17.1 AstraZeneca Corporate Summary
7.17.2 AstraZeneca Business Overview
7.17.3 AstraZeneca Migraine Therapeutics Major Product Offerings
7.17.4 AstraZeneca Migraine Therapeutics Revenue in Global Market (2017-2022)
7.17.5 AstraZeneca Key News
7.18 Amirall
7.18.1 Amirall Corporate Summary
7.18.2 Amirall Business Overview
7.18.3 Amirall Migraine Therapeutics Major Product Offerings
7.18.4 Amirall Migraine Therapeutics Revenue in Global Market (2017-2022)
7.18.5 Amirall Key News
7.19 OptiNose
7.19.1 OptiNose Corporate Summary
7.19.2 OptiNose Business Overview
7.19.3 OptiNose Migraine Therapeutics Major Product Offerings
7.19.4 OptiNose Migraine Therapeutics Revenue in Global Market (2017-2022)
7.19.5 OptiNose Key News
7.20 Revance Therapeutics
7.20.1 Revance Therapeutics Corporate Summary
7.20.2 Revance Therapeutics Business Overview
7.20.3 Revance Therapeutics Migraine Therapeutics Major Product Offerings
7.20.4 Revance Therapeutics Migraine Therapeutics Revenue in Global Market (2017-2022)
7.20.5 Revance Therapeutics Key News
7.21 RedHill Biopharma
7.21.1 RedHill Biopharma Corporate Summary
7.21.2 RedHill Biopharma Business Overview
7.21.3 RedHill Biopharma Migraine Therapeutics Major Product Offerings
7.21.4 RedHill Biopharma Migraine Therapeutics Revenue in Global Market (2017-2022)
7.21.5 RedHill Biopharma Key News
7.22 Bausch Health
7.22.1 Bausch Health Corporate Summary
7.22.2 Bausch Health Business Overview
7.22.3 Bausch Health Migraine Therapeutics Major Product Offerings
7.22.4 Bausch Health Migraine Therapeutics Revenue in Global Market (2017-2022)
7.22.5 Bausch Health Key News
7.23 NeurAxon
7.23.1 NeurAxon Corporate Summary
7.23.2 NeurAxon Business Overview
7.23.3 NeurAxon Migraine Therapeutics Major Product Offerings
7.23.4 NeurAxon Migraine Therapeutics Revenue in Global Market (2017-2022)
7.23.5 NeurAxon Key News
7.24 Biohaven Pharma
7.24.1 Biohaven Pharma Corporate Summary
7.24.2 Biohaven Pharma Business Overview
7.24.3 Biohaven Pharma Migraine Therapeutics Major Product Offerings
7.24.4 Biohaven Pharma Migraine Therapeutics Revenue in Global Market (2017-2022)
7.24.5 Biohaven Pharma Key News
7.25 Eisai
7.25.1 Eisai Corporate Summary
7.25.2 Eisai Business Overview
7.25.3 Eisai Migraine Therapeutics Major Product Offerings
7.25.4 Eisai Migraine Therapeutics Revenue in Global Market (2017-2022)
7.25.5 Eisai Key News
7.26 Valeant Pharma
7.26.1 Valeant Pharma Corporate Summary
7.26.2 Valeant Pharma Business Overview
7.26.3 Valeant Pharma Migraine Therapeutics Major Product Offerings
7.26.4 Valeant Pharma Migraine Therapeutics Revenue in Global Market (2017-2022)
7.26.5 Valeant Pharma Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Migraine Therapeutics Market Opportunities & Trends in Global Market
Table 2. Migraine Therapeutics Market Drivers in Global Market
Table 3. Migraine Therapeutics Market Restraints in Global Market
Table 4. Key Players of Migraine Therapeutics in Global Market
Table 5. Top Migraine Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Migraine Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Migraine Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Migraine Therapeutics Product Type
Table 9. List of Global Tier 1 Migraine Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Migraine Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Migraine Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Migraine Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Migraine Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Migraine Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Migraine Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Migraine Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Migraine Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Migraine Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Migraine Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Migraine Therapeutics Product Offerings
Table 32. Allergan Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Migraine Therapeutics Product Offerings
Table 35. Merck Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Migraine Therapeutics Product Offerings
Table 38. Pfizer Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Teva Corporate Summary
Table 40. Teva Migraine Therapeutics Product Offerings
Table 41. Teva Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Amgen Corporate Summary
Table 43. Amgen Migraine Therapeutics Product Offerings
Table 44. Amgen Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Migraine Therapeutics Product Offerings
Table 47. Johnson & Johnson Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Endo International Corporate Summary
Table 49. Endo International Migraine Therapeutics Product Offerings
Table 50. Endo International Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Migraine Therapeutics Product Offerings
Table 53. GlaxoSmithKline Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Impax Corporate Summary
Table 55. Impax Migraine Therapeutics Product Offerings
Table 56. Impax Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Abbott Corporate Summary
Table 58. Abbott Migraine Therapeutics Product Offerings
Table 59. Abbott Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Bayer Corporate Summary
Table 61. Bayer Migraine Therapeutics Product Offerings
Table 62. Bayer Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Eli Lilly Corporate Summary
Table 64. Eli Lilly Migraine Therapeutics Product Offerings
Table 65. Eli Lilly Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Novartis International Corporate Summary
Table 67. Novartis International Migraine Therapeutics Product Offerings
Table 68. Novartis International Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Ethypharm Corporate Summary
Table 70. Ethypharm Migraine Therapeutics Product Offerings
Table 71. Ethypharm Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Kowa Pharmaceuticals America Corporate Summary
Table 73. Kowa Pharmaceuticals America Migraine Therapeutics Product Offerings
Table 74. Kowa Pharmaceuticals America Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. Winston Pharmaceuticals Corporate Summary
Table 76. Winston Pharmaceuticals Migraine Therapeutics Product Offerings
Table 77. Winston Pharmaceuticals Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 78. AstraZeneca Corporate Summary
Table 79. AstraZeneca Migraine Therapeutics Product Offerings
Table 80. AstraZeneca Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 81. Amirall Corporate Summary
Table 82. Amirall Migraine Therapeutics Product Offerings
Table 83. Amirall Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 84. OptiNose Corporate Summary
Table 85. OptiNose Migraine Therapeutics Product Offerings
Table 86. OptiNose Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 87. Revance Therapeutics Corporate Summary
Table 88. Revance Therapeutics Migraine Therapeutics Product Offerings
Table 89. Revance Therapeutics Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 90. RedHill Biopharma Corporate Summary
Table 91. RedHill Biopharma Migraine Therapeutics Product Offerings
Table 92. RedHill Biopharma Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 93. Bausch Health Corporate Summary
Table 94. Bausch Health Migraine Therapeutics Product Offerings
Table 95. Bausch Health Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 96. NeurAxon Corporate Summary
Table 97. NeurAxon Migraine Therapeutics Product Offerings
Table 98. NeurAxon Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 99. Biohaven Pharma Corporate Summary
Table 100. Biohaven Pharma Migraine Therapeutics Product Offerings
Table 101. Biohaven Pharma Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 102. Eisai Corporate Summary
Table 103. Eisai Migraine Therapeutics Product Offerings
Table 104. Eisai Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 105. Valeant Pharma Corporate Summary
Table 106. Valeant Pharma Migraine Therapeutics Product Offerings
Table 107. Valeant Pharma Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 1. Migraine Therapeutics Market Opportunities & Trends in Global Market
Table 2. Migraine Therapeutics Market Drivers in Global Market
Table 3. Migraine Therapeutics Market Restraints in Global Market
Table 4. Key Players of Migraine Therapeutics in Global Market
Table 5. Top Migraine Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Migraine Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Migraine Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Migraine Therapeutics Product Type
Table 9. List of Global Tier 1 Migraine Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Migraine Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Migraine Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Migraine Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Migraine Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Migraine Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Migraine Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Migraine Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Migraine Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Migraine Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Migraine Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Migraine Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Migraine Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Allergan Corporate Summary
Table 31. Allergan Migraine Therapeutics Product Offerings
Table 32. Allergan Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Migraine Therapeutics Product Offerings
Table 35. Merck Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Migraine Therapeutics Product Offerings
Table 38. Pfizer Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Teva Corporate Summary
Table 40. Teva Migraine Therapeutics Product Offerings
Table 41. Teva Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Amgen Corporate Summary
Table 43. Amgen Migraine Therapeutics Product Offerings
Table 44. Amgen Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Migraine Therapeutics Product Offerings
Table 47. Johnson & Johnson Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Endo International Corporate Summary
Table 49. Endo International Migraine Therapeutics Product Offerings
Table 50. Endo International Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Migraine Therapeutics Product Offerings
Table 53. GlaxoSmithKline Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Impax Corporate Summary
Table 55. Impax Migraine Therapeutics Product Offerings
Table 56. Impax Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Abbott Corporate Summary
Table 58. Abbott Migraine Therapeutics Product Offerings
Table 59. Abbott Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Bayer Corporate Summary
Table 61. Bayer Migraine Therapeutics Product Offerings
Table 62. Bayer Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Eli Lilly Corporate Summary
Table 64. Eli Lilly Migraine Therapeutics Product Offerings
Table 65. Eli Lilly Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Novartis International Corporate Summary
Table 67. Novartis International Migraine Therapeutics Product Offerings
Table 68. Novartis International Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Ethypharm Corporate Summary
Table 70. Ethypharm Migraine Therapeutics Product Offerings
Table 71. Ethypharm Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Kowa Pharmaceuticals America Corporate Summary
Table 73. Kowa Pharmaceuticals America Migraine Therapeutics Product Offerings
Table 74. Kowa Pharmaceuticals America Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. Winston Pharmaceuticals Corporate Summary
Table 76. Winston Pharmaceuticals Migraine Therapeutics Product Offerings
Table 77. Winston Pharmaceuticals Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 78. AstraZeneca Corporate Summary
Table 79. AstraZeneca Migraine Therapeutics Product Offerings
Table 80. AstraZeneca Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 81. Amirall Corporate Summary
Table 82. Amirall Migraine Therapeutics Product Offerings
Table 83. Amirall Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 84. OptiNose Corporate Summary
Table 85. OptiNose Migraine Therapeutics Product Offerings
Table 86. OptiNose Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 87. Revance Therapeutics Corporate Summary
Table 88. Revance Therapeutics Migraine Therapeutics Product Offerings
Table 89. Revance Therapeutics Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 90. RedHill Biopharma Corporate Summary
Table 91. RedHill Biopharma Migraine Therapeutics Product Offerings
Table 92. RedHill Biopharma Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 93. Bausch Health Corporate Summary
Table 94. Bausch Health Migraine Therapeutics Product Offerings
Table 95. Bausch Health Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 96. NeurAxon Corporate Summary
Table 97. NeurAxon Migraine Therapeutics Product Offerings
Table 98. NeurAxon Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 99. Biohaven Pharma Corporate Summary
Table 100. Biohaven Pharma Migraine Therapeutics Product Offerings
Table 101. Biohaven Pharma Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 102. Eisai Corporate Summary
Table 103. Eisai Migraine Therapeutics Product Offerings
Table 104. Eisai Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
Table 105. Valeant Pharma Corporate Summary
Table 106. Valeant Pharma Migraine Therapeutics Product Offerings
Table 107. Valeant Pharma Migraine Therapeutics Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Migraine Therapeutics Segment by Type in 2021
Figure 2. Migraine Therapeutics Segment by Application in 2021
Figure 3. Global Migraine Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Migraine Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Migraine Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Migraine Therapeutics Revenue in 2021
Figure 8. By Type - Global Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Amgen Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Endo International Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Impax Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Abbott Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bayer Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Eli Lilly Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Novartis International Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Ethypharm Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Kowa Pharmaceuticals America Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Winston Pharmaceuticals Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. AstraZeneca Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Amirall Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. OptiNose Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Revance Therapeutics Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. RedHill Biopharma Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Bausch Health Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. NeurAxon Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Biohaven Pharma Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Eisai Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Valeant Pharma Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Migraine Therapeutics Segment by Type in 2021
Figure 2. Migraine Therapeutics Segment by Application in 2021
Figure 3. Global Migraine Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Migraine Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Migraine Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Migraine Therapeutics Revenue in 2021
Figure 8. By Type - Global Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Migraine Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Migraine Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Amgen Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Endo International Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Impax Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Abbott Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bayer Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Eli Lilly Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Novartis International Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Ethypharm Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Kowa Pharmaceuticals America Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Winston Pharmaceuticals Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. AstraZeneca Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Amirall Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. OptiNose Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Revance Therapeutics Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. RedHill Biopharma Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Bausch Health Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. NeurAxon Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Biohaven Pharma Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Eisai Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Valeant Pharma Migraine Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
